GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medite Cancer Diagnostics Inc (OTCPK:MDIT) » Definitions » Policyholder Funds

MDIT (Medite Cancer Diagnostics) Policyholder Funds


View and export this data going back to . Start your Free Trial

What is Medite Cancer Diagnostics Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Medite Cancer Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
10524 Moss Park Road, Suite 204-357, Orlando, FL, USA, 32832
Medite Cancer Diagnostics Inc is a US-based company that specializes in the marketing and selling of MEDITE core products (instruments and consumables), manufacturing, development of new solutions in histology and cytology, and marketing of molecular biomarkers. The company manufactures medical devices and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company operates through a single segment for cancer diagnostics instruments and consumables for histology and cytology laboratories. It offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis.
Executives
Lewis William Austin Iv director, 10 percent owner 201 E 87TH STREET, APT 5H, NEW YORK NY 10128
John H Abeles director 2365 NW 41ST STREET BOCA RATON FL 33431
Joel S Kanter director C/O APPLIED UV, INC., 150 N. MACQUESTEN PKWY, MOUNT VERNON NY 10550
Clinton Severson director C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587